Supplementary Table 1. Oligonucleotides Used in This Study s1

Supplementary Table 1. Oligonucleotides Used in This Study s1

<p> Supplementary Table 1. Oligonucleotides used in this study.</p><p>Oligonucleotide Sequence (5’- 3’)a Targetb NotI-WdV001 GCGGCCGCATGGCAGGAAGAAGCGGAG 5551 - 5570 WdV002 CATCAAGTTTCTCTATCAAAGCAACCCACCTC 5603 - 5626 WdV003 CAAAGCAACCCACCTCCCAACCCCGAG 7972 - 7992 NotI-WdV004 GGAGTCAGGAACTAAAGAATAGCGGCCGC 8225 - 8246 NotI-WdV005 GCGGCCGCATGGAGCCAGTAGATCCTAGAC 5412 - 5434 WdV006 CATCAAGTTTCTCTATCAAAGCAACCCACCTC 5603 - 5626 WdV007 CTATCAAAGCAACCCACCTCCCAACCCCGAGG 7972 - 7993 NotI-WdV008 GGAGTCAGGAACTAAAGAATAGCGGCCGC 8225 - 8246 NotI-WdV011 ATAAGAATGCGGCCGCATGGGTGGCAAGTGGTCAA 8390 - 8416 AAAGTAG NotI-WdV012 ATAGTTTAGCGGCCGCTCAGCAGTTCTTGAAGTACT 8983 - 9010 CCGGATG WdV020 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCA attB1-hrGFP TGGTGAGCAAGCAGATCCTG WdV021 GCAGCCTGCACGAGTGGGTGTAATACCCAGCTTTC attB2-hrGFP TTGTACAAAGTGGTCCCC WdV022 CCCAAGCTTGCGTAGAACCTGCGGCCGCTAATCTC polylinker GTGCGAG WdV023 GCAAGGCCTAGGCGATGATAGTTATGAGAGCTCGC ACGAGATTAGCGGCC polylinker WdV024 CGCCTAGGCCTTGCTTCGCTCGAGCATCTGATTCGC polylinker CGGTGATCCG WdV025 AGCTACAAGCATGCACGATACAGTTAATTAAAACG polylinker GATCACCGGCGAATC SphI-WdV034 ACATGCATGCTGGGGATGCGGTGGGCTCTATGGAT EF1α promoter GTCGCGTGAGGCTCCGGTGCCCG WdV035 CAAAGTTTTTTTCTTCCATTTCAGGTGTCGTGATTC EF1α promoter ACCATGGAG WdV036 GGTGTCGTGATTCACCATGGAGGGCTGCGGCAAGG hrGFP GCAACATCCTG BamHI-WdV037 CGGGATCCCGAGGCCGGTGATGGTCTTCTTCATCAC hrGFP GGGGCCGTCG BamHI-WdV038 CGGGATCCGCCCTTGTACTCCACGCGGTACACGAA hrGFP CATCTC WdV039 TGCCCTTGCCGCAGCCCTCCATGGTGAATTTACTTG hrGFP C WdV040 CCCTCCATGGTGAATTTACTTGCTTTAAAAAACCTC SV40 pA CCAC EcoRI-WdV041 GGAATTCACATGCATGCTGGGGATGCGGTGGGCTCT SV40 pA ATGGTGCAGACATGATAAGATACATTGATGAGTTT GGAC HindIII-WdV047 CCCAAGCTTGGGCGTGAGGCTCCGGTGC EF1α promoter WdV049 AGGTGTCGTGATATTCCTTCGGGCCTGTCG 7997 - 7978 NotI-WdV050 GCTCTAGTCTAGGATCTGCGGCCGCTAAACTATT 5422 - 5405 AvrII-WdV051 GTCCTAGGAGATCCTAGACTAGAGCCCTG 5874 - 5895 WdV52 CAGGCCCGAAGGAATACTGTGCCTTCTAGTT 8000 - 8016 NotI-WdV053 CCGCGGCCGCGAAGGAATACTGTGCCTTCTAGTTG BGH-polyA CCAGC PacI- WdV054 CCTTAATTAACCATAGAGCCCACCGCATC BGH-polyA WdV055 TCAAATATTGGTGTCACGACACCTGAAATG EF1α promoter Oligonucleotide Sequence (5’- 3’) Target WdV056 AGGTGTCGTGACACCAATATTTGAGGGCTTC 8187 - 8167 NotI-WdV057 GAGGTCTTCGTCGCTGTCTCCGCTGCGGCCGCTAAA 5562 - 5538 CTAT AvrII-WdV058 AGCCTAGGAGCGGAGACAGCGACGAAGAC 5562 - 5583 WdV059 GAAGCCCTCAAATATTGGTGCTGTGCCTTC 8187 - 8207 WdV60 CTAGAAGGCACAGCACCAATATTTGAG BGH-polyA WdV061 GATGGTGCTACTCACGACACCTGAAATGGAAG EF1α promoter WdV062 CAGGTGTCGTGAGTAGCACCATCCAAAGG 8801 - 8784 NotI-WdV063 ATAGTTTAGCGGCCGCACAAGTAGCAATACAGCAG 8542 - 8518 CTACC AvrII-WdV064 AGCCTAGGACAAGTAGCAATACAGCAGCTAC 8518 - 8541 WdV065 AGAAGGCACAGGTAGCACCATCCAAAGGTC 8799 - 8818 WdV066 GATGGTGCTACCTGTGCCTTCTAGTTGCCAGC BGH-polyA PKF2 TCGTGCGAGCTCTCATAACTATC BGH-polyA NotI-PKR2 GATAGTTATGAGAGCTCGCAC pEF1α promoter HindIII-PKF4 CAGAAGCTTCTTCCATTTCAGGTGTCGTG pEF1α promoter BamHI-PKR4 ATAGGATCCTCGAGCCATAGAGCCCACCGC BGH-polyA AT SalI-PKF5 CACGTCGACTGCAGATATCTAGCATTTCATCACGTG -179 - –161 G HindIII-PKR5 CGGAATGCC AAGCTT TATTGAGGCTTAAGCAG 59 - 81 SalI-PKF6 GACGTCGACTGCAGATATCCTTTCGTCTTCAAGAAT 7tetO TCC HindIII-PKR6 TCGAAGCTTAGGTCAAAACAGCGTGGATGGC 7tetO PKF8 GGCCGCAATTGATAGGTATCTAGACCTAGGCCGCG polylinker GATCCGATATCACGTGCCGC XbaI-PKR9 AGCTCTAGACACGACACCTGAAATGGAAG polylinker PKR13 GGCACGTGATATCGGATCCGCGGCCTAGGTCTAGA polylinker TACCTATCAATTGC MunI-PKF13 GATCAATTGCCGCCAGAACACAGGTAAG EF1α intron SacI-T7p-PKF16 CAGGAGCTCCAAAAAAAAGCCCGCTCATTAGGCGGG 8416 - 8438 CGCGTAATACGACTCACTATAGGGTGGTTGGATG GCCTACTGTAA asT7p-XbaI- GATTCTAGACAAAAAAAAGCCCGCTCATTAGGCGGG 8674 - 8695 PKR16 CGCGTAATACGACTCACTATAGGGTGAATTAGCC CTTCCAGTCC NcoI-PKF21 CATGGGTGCCTGGCTAGAAGCACATTCAAGAGATG 8552 - 8571 TGCTTCTAGCCAGGCACTTG BamHI-PKR21 GATCCAAGTGCCTGGCTAGAAGCAGATCTCTTGAAT 8552 - 8571 GTGCTTCTAGCCAGGCACC Nef-B/X ATCCCGGGATCCACCTCAGGTACCTTTAAGAC 8552 - 8603 AntiU3-att TGGAAGGGCTAATTCACTCC 8650 - 8631 IFN-βF GATTCATCTAGCACTGGCTGG Human IFN-β IFN-βR CTTCAGGTAATGCAGAATCC gene</p><p> a HIV sequences are underlined and restriction sites are in italics. T7 promoter sequences are</p><p> in bold, T7 terminator are in bold and italics. b Numbers refer to the nucleotide position on the</p><p> genomic HIV-1 RNA transcript, with +1 being the capped G residue. </p>

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    2 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us